Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 


Interaction of celecoxib with aspirin

Mehwish Nawaz Qaisrani, Shabana Ali, Kulsoom Farhat, Ayesha Janjua, Imrana Maqsood, Faisal Afridi.

Abstract
Objective: To assess the celecoxib interference with the anti-platelet effect of low dose aspirin.
Methodology: We selected eighteen healthy volunteers, aged between 22 and 50 years and allocated them into three groups. After written informed consent the three groups (A,B and C) were given aspirin (10mg once a day), celecoxib (200mg twice a day) and both aspirin and celecoxib each. The drugs were administered for six consecutive days, prohibiting the concomitant use of any other drug. We obtained blood samples from the study subjects on two occasions, before starting drugs and then on the seventh day and analyzed them for platelet aggregation (ADP and collagen induced) and serum thromboxane A2 levels.
Results: If 150mg aspirin is taken daily along with twice daily doses of celecoxib (200mg), aspirin continues to exert an antiplatelet effect. Results show that mean platelet aggregation with ADP was reduced to 60.006.19 percent from a baseline value of 83.334.77 percent. When collagen was used as a reagent the aggregation of platelets was markedly reduced to 34.507.71 from a baseline of 79.175.83 percent. Similarly, mean thromboxane B2 levels reduced markedly from 854.8851.18pg/ml to 539.9486.84 pg/ml.
Conclusion: It is safe to use celecoxib with aspirin, as the anti-platelet effect of the latter is not attenuated.

Key words: Non-steroidal anti-inflammatory drugs, aspirin, celecoxib.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mehwish Nawaz Qaisrani
Articles by Shabana Ali
Articles by Kulsoom Farhat
Articles by Ayesha Janjua
Articles by Imrana Maqsood
Articles by Faisal Afridi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Qaisrani MN, Ali S, Farhat K, Janjua A, Maqsood I, Afridi F. Interaction of celecoxib with aspirin. RMJ. 2021; 46(1): 48-51.


Web Style

Qaisrani MN, Ali S, Farhat K, Janjua A, Maqsood I, Afridi F. Interaction of celecoxib with aspirin. http://www.rmj.org.pk/?mno=60655 [Access: March 20, 2021].


AMA (American Medical Association) Style

Qaisrani MN, Ali S, Farhat K, Janjua A, Maqsood I, Afridi F. Interaction of celecoxib with aspirin. RMJ. 2021; 46(1): 48-51.



Vancouver/ICMJE Style

Qaisrani MN, Ali S, Farhat K, Janjua A, Maqsood I, Afridi F. Interaction of celecoxib with aspirin. RMJ. (2021), [cited March 20, 2021]; 46(1): 48-51.



Harvard Style

Qaisrani, M. N., Ali, . S., Farhat, . K., Janjua, . A., Maqsood, . I. & Afridi, . F. (2021) Interaction of celecoxib with aspirin. RMJ, 46 (1), 48-51.



Turabian Style

Qaisrani, Mehwish Nawaz, Shabana Ali, Kulsoom Farhat, Ayesha Janjua, Imrana Maqsood, and Faisal Afridi. 2021. Interaction of celecoxib with aspirin. Rawal Medical Journal, 46 (1), 48-51.



Chicago Style

Qaisrani, Mehwish Nawaz, Shabana Ali, Kulsoom Farhat, Ayesha Janjua, Imrana Maqsood, and Faisal Afridi. "Interaction of celecoxib with aspirin." Rawal Medical Journal 46 (2021), 48-51.



MLA (The Modern Language Association) Style

Qaisrani, Mehwish Nawaz, Shabana Ali, Kulsoom Farhat, Ayesha Janjua, Imrana Maqsood, and Faisal Afridi. "Interaction of celecoxib with aspirin." Rawal Medical Journal 46.1 (2021), 48-51. Print.



APA (American Psychological Association) Style

Qaisrani, M. N., Ali, . S., Farhat, . K., Janjua, . A., Maqsood, . I. & Afridi, . F. (2021) Interaction of celecoxib with aspirin. Rawal Medical Journal, 46 (1), 48-51.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED,  Scopus and Web of Science

                     Approved by the Higher Education Commission of Pakistan 


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.